Research and Development
SISAF collaborates closely with the Nanotechnology and Integrated BioEngineering Centre (NIBEC) at the University of Ulster.
SiSafe
SISAF's R&D team is researching the use of our platform technology for a wide range of applications in cosmetics and skincare, as well as the treatment of skin conditions, such as skin melanoma, Acne or Psoriasis.
We are also exploring the medical use of SiSafe for the topical, needle-free treatment of non-dermal conditions, such as cancer, Alzheimer disease, or diabetes.
New IP
In addition to SISAF's platform technology, we are constantly expanding our IP portfolio of innovative drug delivery solutions.
Biocompatibility – dissolves to the natural form
Bioactive Delivery – carrier acts as active compound
Stability – increases compound stability
Solubility – improves compound solubility
Skin Penetration – reaches deeper skin layers
Controlled Release – tailor-made release profile
Localization – avoids systemic absorption when needed
